Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115286578B reveals a metal-free route for trifluoromethyl pyrazole synthesis. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel rare earth catalyzed method for aromatic formamide and olefin. Offers mild conditions and high purity for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed carbonylation method for quinolinones. Offers cost reduction and scalable supply for pharmaceutical intermediate manufacturing.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering significant cost reduction in API manufacturing and scalable production.
Patent CN102863387A reveals a copper-catalyzed route for imidazolium salts, offering high yields and mild conditions for reliable ionic liquid and catalyst precursor manufacturing.
Patent CN115536605B details iridium-catalyzed oxazole synthesis enabling efficient COX-2 inhibitor production with reduced steps and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN113735778B enables efficient synthesis of 5-trifluoromethyl imidazole. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Patent CN108047125A details a low-cost synthesis route for Argatroban intermediates. Achieve high purity and scalable supply chain reliability with optimized manufacturing processes.
Novel palladium-catalyzed carbonylation method offers high efficiency and significant cost reduction for pharmaceutical intermediate manufacturing supply chains globally.
Patent CN117164555A reveals cobalt-catalyzed route for indole carboxamides. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates supply chain optimization.
Novel route avoids DKP impurities, offering high purity and yield for cost-effective pharmaceutical manufacturing and scalable supply chains.
Patent CN110922369B reveals a mild Cu-catalyzed route to trifluoromethyl dihydrofuran amines, offering cost reduction and scalable supply for pharmaceutical intermediates.
Novel catalytic dehydrogenation route for 2-indol-3-yl-quinolines offers high purity and scalable manufacturing for global pharmaceutical intermediates supply chains.
Patent CN106946881A reveals a Rh-catalyzed one-pot route to amino-substituted naphthoquinazinones, offering mild conditions and broad substrate scope for cost-effective manufacturing.
Patent CN114920707B reveals a novel iodine-promoted cyclization using DMF as a carbon source, offering significant cost reduction in API manufacturing and simplified supply chains.
Patent CN108864164B details a green Pd-catalyzed method for 2-alkynyl indoles using water solvent, offering high regioselectivity and cost-effective manufacturing for pharma intermediates.
Patent CN116253692A reveals a novel room-temperature synthesis for trifluoromethyl 1,2,4-triazines, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel glucose-based route for high-purity triazole intermediates. Reduces cost and simplifies supply chain for pharma manufacturing partners globally.
Patent CN113683595B reveals sulfur-promoted triazole synthesis offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Discover a novel one-step TEMPO dehydrocyclization method for benzoxazole derivatives. Offers cost reduction in API manufacturing and scalable green chemistry solutions.